New software, created by scientists at Imperial College London and the University of Edinburgh, has been able to identify and measure the severity of small vessel disease, one of the commonest causes of stroke and dementia. The study, published in Radiology, took place at Charing Cross Hospital, part of Imperial College Healthcare NHS Trust.
Researchers say that this technology can help clinicians to administer the best treatment to patients more quickly in emergency settings – and predict a person’s likelihood of developing dementia. The development may also pave the way for more personalised medicine.
Dr Paul Bentley, lead author and Clinical Lecturer at Imperial College London, said:
“This is the first time that machine learning methods have been able to accurately measure a marker of small vessel disease in patients presenting with stroke or memory impairment who undergo CT scanning. Our technique is consistent and achieves high accuracy relative to an MRI scan – the current gold standard technique for diagnosis. This could lead to better treatments and care for patients in everyday practice.”
Professor Joanna Wardlaw, Head of Neuroimaging Sciences at the University of Edinburgh, added: “This is a first step in making a scan reading tool that could be useful in mining large routine scan datasets and, after more testing, might aid patient assessment at hospital admission with stroke.”
Small vessel disease (SVD) is a very common neurological disease in older people that reduces blood flow to the deep white matter connections of the brain, damaging and eventually killing the brain cells. It causes stroke and dementia as well as mood disturbance. SVD increases with age but is accelerated by hypertension and diabetes.
At the moment, doctors diagnose SVD by looking for changes to white matter in the brain during MRI or CT scans. However, this relies on a doctor gauging from the scan how far the disease has spread. In CT scans it is often difficult to decide where the edges of the SVD are, making it difficult to estimate the severity of the disease, explains Dr Bentley.
Although MRI can detect and measure SVD more sensitively it is not the most common method used due to scanner availability, and suitability for emergency or older patients.
Dr Bentley added: “Current methods to diagnose the disease through CT or MRI scans can be effective, but it can be difficult for doctors to diagnose the severity of the disease by the human eye. The importance of our new method is that it allows for precise and automated measurement of the disease. This also has applications for widespread diagnosis and monitoring of dementia, as well as for emergency decision-making in stroke.”
Dr Bentley explains that this software could help influence doctors decision-making in emergency neurological conditions and lead to more personalised medicine. For example, in stroke, treatments such as ‘clot busting medications’ can be quickly administered to unblock an artery. However, these treatments can be hazardous by causing bleeding, which becomes more likely as the amount of SVD increases. The software could be applied in future to estimate the likely risk of haemorrhage in patients and doctors can decide on a personal basis, along with other factors, whether to treat or not with clot busters.
He also suggests that the software can help quantify the likelihood of patients developing dementia or immobility, due to slowly progressive SVD. This would alert doctors to potentially reversible causes such as high blood pressure or diabetes.
The study used historical data of 1082 CT scans of stroke patients across 70 hospitals in the UK between 2000-2014, including cases from the Third International Stroke Trial. The software identified and measured a marker of SVD, and then gave a score indicating how severe the disease was ranging from mild to severe. The researchers then compared the results to a panel of expert doctors who estimated SVD severity from the same scans. The level of agreement of the software with the experts was as good as agreements between one expert with another.
Additionally, in 60 cases they obtained MRI and CT in the same subjects, and used the MRI to estimate the exact amount of SVD. This showed that the software is 85 per cent accurate at predicting how severe SVD is.
The team are now using similar methods to measure the amount of brain shrinkage and other types of conditions commonly diagnosed on brain CT
The Latest on: Artificial intelligence diagnostics
via Google News
The Latest on: Artificial intelligence diagnostics
- FLANDERS Partners with Augury to Offer Continuous Machine Diagnostics on February 19, 2019 at 6:01 am
Augury’s unique algorithm-powered approach to system diagnostics provides actionable ... machines more reliable by combining two key shifts in the industry: artificial intelligence and the Internet of ... […]
- Genomenon and Diploid Sign Partnership Agreement to Accelerate Rare Disease Diagnostics on February 18, 2019 at 11:48 pm
Its Moon platform is the first software worldwide to use artificial intelligence for rare disease diagnostics. Thanks to its use of advanced machine learning and deep phenotype integration, Moon is no... […]
- Artificial Intelligence in Healthcare Market 2023: Industry Size, Growth Factors, Trends, and Top Companies Analysis for Business Development on February 18, 2019 at 11:35 pm
Investments are likely to flow towards artificial intelligence as it mitigates challenges prevailing ... By end-user, the market is segmented into hospital & diagnostic centers, pharmaceutical & biote... […]
- Getting answers from a chatbot: Empowering patients through artificial intelligence on February 18, 2019 at 10:42 am
Quest Diagnostics is a company that has started using the Microsoft chatbot already, and the following was reported from Venturebeat: Multibillion-dollar diagnostic services provider Quest Diagnostics ... […]
- Cancer Diagnostics Startup Paige.AI Names Med-Tech Executive Leo Grady CEO on February 18, 2019 at 8:00 am
Paige.AI, launched last year with $25 million in venture capital and a licensing deal with Memorial Sloan Kettering Cancer Center, has hired a chief executive to lead the development of a product aime... […]
- Artificial Intelligence in Healthcare Market Size, Share, Trends, Technology By 2023 Ready to Grow at 51.9% on February 15, 2019 at 9:48 pm
By mode of end-user, the global Artificial Intelligence in Healthcare market has been segmented into pharmaceutical & biotechnology companies, hospital & diagnostic centers, and academic & research la... […]
- Hospital Artificial Intelligence Market Will Reach $50 Billion Dollars By 2023 - Focuses On Top Manufacturers Such As General Electric and IBM on February 14, 2019 at 10:17 pm
The 2017 study has 90 pages, 35 tables and figures. Worldwide markets are poised to achieve continuing growth as the artificial intelligence software increases diagnostic excellence, saving lives and ... […]
- Conway Medical Center weighs in on artificial intelligence in healthcare on February 14, 2019 at 5:03 am
Artificial intelligence in the healthcare industry uses human-created ... improve preventative medicine and enhance diagnostics. Results from an Accenture report estimated that AI applications in heal... […]
- Medical imaging and artificial intelligence: naturally compatible on February 14, 2019 at 12:20 am
Tiredness and difficulty in focusing can affect diagnostic accuracy ... assisted by additional information/intelligence, either human or artificial. When asked if she thinks the issue of doctors becom... […]
via Bing News